Notably, the expression of miR-132 is impaired in Alzheimer’s disease (AD) brains (Lau et al. 2013; Soreq 2015), while Mmp9 levels were shown to be elevated in the plasma of AD patients as compared to controls (Lorenzl et al. 2003). Here, MMP9 is linked to Alzheimer disease.